CitronResearch Exposes Another Secret Subsidiary At ArthroCare (ARTC)
Tweet
Share
E-mailGet Alerts ARTC Hot Sheet
Join SI Premium – FREE
Today, CitronResearch exposes another secret subsidiary at ArthroCare (Nasdaq: ARTC). It has uncovered that ArthroCare has yet another surgical device "billing solution" company operating in its shadows.
It is the opinion of Citron Research that Arthrocare is committing fraud on the investing public. Citron said, "Just when they thought they could sweep the truth under the rug about their "Discocare" aquisition, Citron exposes Device Reimbursement Services. It is time management makes sure their D&O insurance is all paid up."
Play, Learn & Win in this $50,000 Stock Trading Contest. Join Today.
It is the opinion of Citron Research that Arthrocare is committing fraud on the investing public. Citron said, "Just when they thought they could sweep the truth under the rug about their "Discocare" aquisition, Citron exposes Device Reimbursement Services. It is time management makes sure their D&O insurance is all paid up."
Play, Learn & Win in this $50,000 Stock Trading Contest. Join Today.
You May Also Be Interested In
- Buy this popular consumer stock, Jefferies urges investors
- This telecom stock is Bernstein's Best Idea
- BMW capital markets day: UBS sees cautious margin targets, Citi urges strategy shift
Create E-mail Alert Related Categories
Hot List, Insiders' Blog, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
